vs
Masco（MAS）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Masco的季度营收约是Steris的1.3倍（$1.9B vs $1.5B），Steris净利率更高（12.9% vs 11.9%，领先1.0%），Steris同比增速更快（9.2% vs 6.5%），过去两年Steris的营收复合增速更高（15.8% vs -4.2%）
美国家居建材企业Masco主营家装及新建住宅市场相关产品，旗下拥有20余家子公司，在全球运营近80座生产工厂，其中美国本土近60座，海外地区超20座。公司1969年于纽交所挂牌上市，后实现快速增长，成功跻身美国财富500强榜单。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
MAS vs STE — 直观对比
营收规模更大
MAS
是对方的1.3倍
$1.5B
营收增速更快
STE
高出2.7%
6.5%
净利率更高
STE
高出1.0%
11.9%
两年增速更快
STE
近两年复合增速
-4.2%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.9B | $1.5B |
| 净利润 | $228.0M | $192.9M |
| 毛利率 | 35.8% | 43.8% |
| 营业利润率 | 16.5% | 18.3% |
| 净利率 | 11.9% | 12.9% |
| 营收同比 | 6.5% | 9.2% |
| 净利润同比 | 14.5% | 11.2% |
| 每股收益（稀释后） | — | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MASSTE
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $1.9B | $1.5B | ||
| Q2 25 | $2.1B | $1.4B | ||
| Q1 25 | $1.8B | $1.5B | ||
| Q4 24 | $1.8B | $1.4B | ||
| Q3 24 | $2.0B | $1.3B | ||
| Q2 24 | $2.1B | $1.3B |
净利润MASSTE
| Q1 26 | $228.0M | — | ||
| Q4 25 | $165.0M | $192.9M | ||
| Q3 25 | $189.0M | $191.9M | ||
| Q2 25 | $270.0M | $177.4M | ||
| Q1 25 | $186.0M | $145.7M | ||
| Q4 24 | $182.0M | $173.5M | ||
| Q3 24 | $167.0M | $150.0M | ||
| Q2 24 | $258.0M | $145.4M |
毛利率MASSTE
| Q1 26 | 35.8% | — | ||
| Q4 25 | 33.9% | 43.8% | ||
| Q3 25 | 34.2% | 44.2% | ||
| Q2 25 | 37.6% | 45.1% | ||
| Q1 25 | 35.8% | 43.3% | ||
| Q4 24 | 34.8% | 44.5% | ||
| Q3 24 | 36.6% | 43.6% | ||
| Q2 24 | 37.5% | 44.7% |
营业利润率MASSTE
| Q1 26 | 16.5% | — | ||
| Q4 25 | 13.8% | 18.3% | ||
| Q3 25 | 15.8% | 18.2% | ||
| Q2 25 | 20.1% | 17.7% | ||
| Q1 25 | 15.9% | 14.6% | ||
| Q4 24 | 15.9% | 17.9% | ||
| Q3 24 | 18.0% | 16.5% | ||
| Q2 24 | 19.0% | 14.5% |
净利率MASSTE
| Q1 26 | 11.9% | — | ||
| Q4 25 | 9.2% | 12.9% | ||
| Q3 25 | 9.9% | 13.1% | ||
| Q2 25 | 13.2% | 12.8% | ||
| Q1 25 | 10.3% | 9.8% | ||
| Q4 24 | 10.0% | 12.7% | ||
| Q3 24 | 8.4% | 11.3% | ||
| Q2 24 | 12.3% | 11.4% |
每股收益（稀释后）MASSTE
| Q1 26 | — | — | ||
| Q4 25 | $0.81 | $1.96 | ||
| Q3 25 | $0.90 | $1.94 | ||
| Q2 25 | $1.28 | $1.79 | ||
| Q1 25 | $0.87 | $1.48 | ||
| Q4 24 | $0.85 | $1.75 | ||
| Q3 24 | $0.77 | $1.51 | ||
| Q2 24 | $1.17 | $1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $423.7M |
| 总债务越低越好 | $2.9B | $1.9B |
| 股东权益账面价值 | $27.0M | $7.2B |
| 总资产 | $5.2B | $10.6B |
| 负债/权益比越低杠杆越低 | 109.07× | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资MASSTE
| Q1 26 | — | — | ||
| Q4 25 | $647.0M | $423.7M | ||
| Q3 25 | $559.0M | $319.2M | ||
| Q2 25 | $390.0M | $279.7M | ||
| Q1 25 | $377.0M | $171.7M | ||
| Q4 24 | $634.0M | $155.2M | ||
| Q3 24 | $646.0M | $172.2M | ||
| Q2 24 | $398.0M | $198.3M |
总债务MASSTE
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.9B | $1.9B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | $2.9B | $2.0B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B |
股东权益MASSTE
| Q1 26 | $27.0M | — | ||
| Q4 25 | $-185.0M | $7.2B | ||
| Q3 25 | $-78.0M | $7.0B | ||
| Q2 25 | $-84.0M | $7.0B | ||
| Q1 25 | $-254.0M | $6.6B | ||
| Q4 24 | $-279.0M | $6.4B | ||
| Q3 24 | $-88.0M | $6.6B | ||
| Q2 24 | $-26.0M | $6.4B |
总资产MASSTE
| Q1 26 | $5.2B | — | ||
| Q4 25 | $5.2B | $10.6B | ||
| Q3 25 | $5.3B | $10.4B | ||
| Q2 25 | $5.3B | $10.4B | ||
| Q1 25 | $5.1B | $10.1B | ||
| Q4 24 | $5.0B | $10.0B | ||
| Q3 24 | $5.3B | $10.2B | ||
| Q2 24 | $5.4B | $10.1B |
负债/权益比MASSTE
| Q1 26 | 109.07× | — | ||
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $298.2M |
| 自由现金流经营现金流 - 资本支出 | — | $199.5M |
| 自由现金流率自由现金流/营收 | — | 13.3% |
| 资本支出强度资本支出/营收 | 1.8% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 1.55× |
| 过去12个月自由现金流最近4个季度 | — | $917.1M |
8季度趋势，按日历期对齐
经营现金流MASSTE
| Q1 26 | — | — | ||
| Q4 25 | $418.0M | $298.2M | ||
| Q3 25 | $456.0M | $287.8M | ||
| Q2 25 | $306.0M | $420.0M | ||
| Q1 25 | $-158.0M | $260.8M | ||
| Q4 24 | $407.0M | $332.8M | ||
| Q3 24 | $416.0M | $250.7M | ||
| Q2 24 | $346.0M | $303.7M |
自由现金流MASSTE
| Q1 26 | — | — | ||
| Q4 25 | $371.0M | $199.5M | ||
| Q3 25 | $415.0M | $201.3M | ||
| Q2 25 | $270.0M | $326.4M | ||
| Q1 25 | $-190.0M | $189.9M | ||
| Q4 24 | $351.0M | $243.6M | ||
| Q3 24 | $378.0M | $148.8M | ||
| Q2 24 | $303.0M | $195.7M |
自由现金流率MASSTE
| Q1 26 | — | — | ||
| Q4 25 | 20.7% | 13.3% | ||
| Q3 25 | 21.6% | 13.8% | ||
| Q2 25 | 13.2% | 23.5% | ||
| Q1 25 | -10.5% | 12.8% | ||
| Q4 24 | 19.2% | 17.8% | ||
| Q3 24 | 19.1% | 11.2% | ||
| Q2 24 | 14.5% | 15.3% |
资本支出强度MASSTE
| Q1 26 | 1.8% | — | ||
| Q4 25 | 2.6% | 6.6% | ||
| Q3 25 | 2.1% | 5.9% | ||
| Q2 25 | 1.8% | 6.7% | ||
| Q1 25 | 1.8% | 4.8% | ||
| Q4 24 | 3.1% | 6.5% | ||
| Q3 24 | 1.9% | 7.7% | ||
| Q2 24 | 2.1% | 8.4% |
现金转化率MASSTE
| Q1 26 | — | — | ||
| Q4 25 | 2.53× | 1.55× | ||
| Q3 25 | 2.41× | 1.50× | ||
| Q2 25 | 1.13× | 2.37× | ||
| Q1 25 | -0.85× | 1.79× | ||
| Q4 24 | 2.24× | 1.92× | ||
| Q3 24 | 2.49× | 1.67× | ||
| Q2 24 | 1.34× | 2.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MAS
暂无分部数据
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
